Medtronic PLC

More Details of Medtronic PLC Company

Company Info

Company codeMDT

Company nameMedtronic PLC

IPO dateNov 21, 1977

Founded at2014

CEOMr. Geoffrey S. (Geoff) Martha

Number of employees95000

Security typeOrdinary Share

Fiscal year-endNov 21

AddressBuilding Two Parkmore Business Park West

CityDUBLIN

Stock exchangeNYSE Consolidated

CountryIreland; Republic of

Postal codeH91 4K49

Phone1135314381700

Websitehttps://www.medtronic.com/

Company codeMDT

IPO dateNov 21, 1977

Founded at2014

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.02M

+0.45%

Mr. Sean M. Salmon

Executive Vice President and President - Cardiovascular Portfolio

543.90K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

486.64K

-0.61%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

111.10K

+90.72%

Mr. Thierry Jean Louis Pieton

Chief Financial Officer, Executive Vice President

61.50K

--

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.33K

-6.34%

Ms. Denise M. O'Leary

Independent Director

48.74K

+0.66%

Mr. Kendall J. (Ken) Powell

Independent Director

46.08K

+2.02%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit

39.00K

-1.45%

Mr. Craig Arnold

Lead Independent Director

38.29K

+0.19%

Name

Name/Position

Position

Shareholding

Change

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.02M

+0.45%

Mr. Sean M. Salmon

Executive Vice President and President - Cardiovascular Portfolio

543.90K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

486.64K

-0.61%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

111.10K

+90.72%

Mr. Thierry Jean Louis Pieton

Chief Financial Officer, Executive Vice President

61.50K

--

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.33K

-6.34%

Revenue Breakdown

Currency: USDUpdate time: Wed, Mar 5

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Surgical & Endoscopy

1.59B

19.24%

Cardiac Rhythm & Heart Failure

1.54B

18.63%

Cranial & Spinal Technologies

1.25B

15.07%

Structural Heart & Aortic

874.00M

10.54%

Specialty Therapies

732.00M

8.82%

Other

2.29B

27.67%

By RegionUSD

Name

Revenue

Proportion

United States

4.23B

51.09%

Rest of World

4.02B

48.56%

Ireland

28.00M

0.33%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Surgical & Endoscopy

1.59B

19.24%

Cardiac Rhythm & Heart Failure

1.54B

18.63%

Cranial & Spinal Technologies

1.25B

15.07%

Structural Heart & Aortic

874.00M

10.54%

Specialty Therapies

732.00M

8.82%

Other

2.29B

27.67%

Shareholder

Update time: Tue, Mar 11

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.63%

BlackRock Institutional Trust Company, N.A.

5.30%

State Street Global Advisors (US)

4.71%

Capital Research Global Investors

2.58%

Geode Capital Management, L.L.C.

2.10%

Other

75.64%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.63%

BlackRock Institutional Trust Company, N.A.

5.30%

State Street Global Advisors (US)

4.71%

Capital Research Global Investors

2.58%

Geode Capital Management, L.L.C.

2.10%

Other

75.64%

Type

Shareholder

Proportion

Investment Advisor/Hedge Fund

39.18%

Investment Advisor

34.56%

Research Firm

3.91%

Pension Fund

2.44%

Hedge Fund

2.15%

Bank and Trust

2.10%

Sovereign Wealth Fund

1.22%

Insurance Company

0.39%

Individual Investor

0.24%

Other

13.75%

Institutional Shareholding

Update time: Thu, Feb 20

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

3660

1.11B

86.96%

+1.10M

2024Q4

3768

1.11B

87.17%

+3.13M

2024Q3

3708

1.09B

85.63%

-24.54M

2024Q2

3725

1.10B

86.25%

-54.15M

2024Q1

3789

1.14B

85.95%

-7.86M

2023Q4

3780

1.13B

85.36%

-20.56M

2023Q3

3761

1.13B

85.37%

-14.93M

2023Q2

3764

1.13B

85.01%

-24.31M

2023Q1

3738

1.13B

85.40%

-14.70M

2022Q4

3689

1.12B

84.79%

-25.97M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

123.63M

9.63%

+776.43K

+0.63%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

68.04M

5.3%

+1.54M

+2.31%

Dec 31, 2024

State Street Global Advisors (US)

60.43M

4.71%

-293.90K

-0.48%

Dec 31, 2024

Capital Research Global Investors

33.20M

2.58%

+571.70K

+1.75%

Dec 31, 2024

Geode Capital Management, L.L.C.

27.05M

2.1%

+574.05K

+2.16%

Dec 31, 2024

JP Morgan Asset Management

24.33M

1.89%

+2.86M

+13.36%

Dec 31, 2024

MFS Investment Management

19.23M

1.49%

-3.63M

-15.91%

Dec 31, 2024

DWS Investment GmbH

14.65M

1.14%

+197.49K

+1.36%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

14.56M

1.13%

-1.01M

-6.49%

Dec 31, 2024

BlackRock Financial Management, Inc.

13.22M

1.03%

+764.34K

+6.13%

Dec 31, 2024

Related ETFs

Update time: Wed, Mar 5

Name

Proportion

Polen Capital International Growth ETF

5.7%

NYLI Healthy Hearts ETF

5.23%

Absolute Select Value ETF

5.12%

iShares U.S. Medical Devices ETF

4.95%

Cullen Enhanced Equity Income ETF

3.85%

iShares Large Cap Value Active ETF

3.84%

USCF Dividend Income Fund

3.67%

American Century Focused Large Cap Value ETF

3.66%

Morgan Dempsey Large Cap Value ETF

3.25%

Madison Covered Call ETF

3.09%

Polen Capital International Growth ETF

Proportion5.7%

NYLI Healthy Hearts ETF

Proportion5.23%

Absolute Select Value ETF

Proportion5.12%

iShares U.S. Medical Devices ETF

Proportion4.95%

Cullen Enhanced Equity Income ETF

Proportion3.85%

iShares Large Cap Value Active ETF

Proportion3.84%

USCF Dividend Income Fund

Proportion3.67%

American Century Focused Large Cap Value ETF

Proportion3.66%

Morgan Dempsey Large Cap Value ETF

Proportion3.25%

Madison Covered Call ETF

Proportion3.09%

Dividend

A total of 16.67B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

May 25, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option

Jun 23, 2023

Jul 14, 2023

Jun 22, 2023

Mar 02, 2023

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023

Mar 24, 2023

Apr 14, 2023

Mar 23, 2023

Dec 08, 2022

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022

Dec 21, 2022

Jan 13, 2023

Dec 20, 2022

Aug 18, 2022

MDT.NB Final Cash Dividend of gross USD 0.68 paid on Oct 14, 2022 going ex on Sep 22, 2022

Sep 23, 2022

Oct 14, 2022

Sep 22, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

92.330USD

Medtronic PLC

92.330

Overview

Company